NEW YORK (TheStreet) -- RATINGS CHANGES
Agco (AGCO) - Get AGCO Corporation Report was upgraded to market perform from underperform by Wells Fargo, which said that sentiment is too negative as the company can exceed near-term earnings expectations.
Avis Budget (CAR) - Get Avis Budget Group, Inc. Report was upgraded to buy from hold by Deutsche Bank, which set a $60 price target, saying that sentiment is overly negative, as the company is facing easier comps in the second half of the year.
Centene (CNC) - Get Centene Corporation Report was upgraded to buy from hold by Jefferies, which set an $88 price target, saying that Centene's acquisition of Health Net (HNT) will create significant financial value for shareholders and enhance the company's strategic positioning.
Guess? (GES) - Get Guess?, Inc. Report was upgraded to market perform from underperform by Telsey Advisory, which set a $23 price target, saying the denim cycle is improving and the new CEO can turn the business around.
Health Net was downgraded to hold from buy by Jefferies, following the company's agreement to be acquired by Centene, as the stock nears Jefferies' $75 price target.
LinkedIn (LNKD) was upgraded to overweight from equal-weight by Barclays, which set a $250 price target, noting that estimates have been reset and can be exceeded in the second half of the year and 2016.
M/A-Com (MTSI) - Get MACOM Technology Solutions Holdings, Inc. Report was upgraded to buy from hold by Drexel Hamilton, which cited valuation, based on a $40 price target.
PTC Therapeutics (PTCT) - Get PTC Therapeutics, Inc. Report was upgraded to overweight from neutral by J.P. Morgan, which set a $100 price target. Phase 3 results for Translarna in non-sense mutation Duchenne Muscular Dystrophy (nmDMD; ACT DMD study) are expected to readout 4Q15, J.P. Morgan said.